Skip to main content

Media

Latest News

April 3, 2020

This week, Congressman Brad Schneider (D-IL) spoke via phone with Vyaire Medical CEO, Guarav Agarwal, and Executive Vice President and General Counsel, Kevin Klemz, about their company's ongoing work to ramp up ventilator production in response to COVID-19.

April 2, 2020
Though I am working from home, I continue to stay in frequent contact with colleagues as we develop additional legislation to address the crisis. I am also keeping in touch with our community, including calls this week with local hospital leaders, with local companies producing and distributing testing, PPE, and medical equipment, including ventilators, with local businesses struggling to manage through this crisis, elected officials, and with people throughout the district to hear their stories and collect their ideas.
April 2, 2020

The bipartisan Congressional Ethylene Oxide Task Force convened a call this week with U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler about the EPA's ongoing ethylene oxide (EtO) rulemaking. Task Force Co-Chairs Reps. Brad Schneider (D-IL) and Jody Hice (R-GA) released the following statement:

March 31, 2020

Today, Congressman Brad Schneider (IL-10) urged the creation of a singular emergency COVID-19 medical supply chain authority, or "supply chain czar," to oversee and coordinate federal efforts surrounding the production, acquisition, and national distribution of medical equipment in response to the coronavirus epidemic.

In a letter to Speaker Nancy Pelosi and House Energy & Commerce Chairman Frank Pallone, Schneider requested they include language creating this position in any future congressional legislation addressing the crisis.

March 31, 2020

As you may already know, last Friday the House of Representatives passed the CARES Act, a historic, bipartisan, $2 trillion relief package to help Americans confront the COVID-19 crisis. While not a perfect bill, I voted for the CARES Act because it will provide desperately needed assistance for our healthcare system, for our workers and their families, for Main Street businesses, and for state and local governments severely affected by this crisis.

March 30, 2020

Three legislative priorities previously introduced by Congressman Brad Schneider (IL-10) to help small businesses and address shortages of medical devices were incorporated into the final version of the Coronavirus Aid, Relief and Economic Security (CARES) Act, which passed the Senate and House with overwhelming bipartisan support and was signed into law on Friday, March 27, 2020.

March 27, 2020

Today, Congressman Brad Schneider released the following statement on his vote in favor of the Coronavirus Aid, Relief and Economic Security (CARES) Act:

"The coronavirus epidemic is a national crisis and an unprecedented challenge for all Americans. That's why today I returned to Washington to help pass the CARES Act and get urgently needed critical resources to our health care providers, workers and families, Main Street businesses, and state and local governments on the frontlines of this crisis.

March 26, 2020

Earlier this week, Congressman Brad Schneider (IL-10) introduced legislation to help American small businesses dealing with economic fallout of the coronavirus (COVID-19) epidemic.

H.R. 6367 would allow small businesses with fewer than 250 employees to spread their net operating losses over a "carryback" period of five years, to provide much needed tax flexibility to hardworking Americans.

March 25, 2020

I hope you and your loved ones are safe, healthy, and managing during these difficult times.

March 25, 2020

Congressman Brad Schneider (IL-10­) announced he will host a second telephone town hall this week to discuss and answer questions related to the coronavirus. More than 8,000 constituents participated on his previous telephone town hall on coronavirus, hosted last week.

He invites all residents of Illinois' Tenth Congressional District to participate this Thursday, March 26, 2020 from 6:30-7:30pm CT.

To participate, constituents are invited to either: